Macrogenics (MGNX) Tops Q3 EPS by 69c, Beats on Revenue

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of $0.90, $0.69 better than the analyst estimate of $0.21. Revenue for the quarter came in at $110.71 million versus the consensus estimate of $87.61 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• XORTX to voluntarily delist from TSX Venture Exchange
• Venu Holding enters $250 million at-the-market stock offering agreement